-
2025-522038-29-00
5
2026-06-16
Locally advanced, unresected (unresectable or medically inoperable or
-
2025-522643-18-00
5
2026-06-16
Stage I NSCLC
-
2025-523586-18-00
5
2026-06-11
Non-Small Cell Lung Cancer
-
2024-511496-14-00
5
2026-05-14
Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic L
-
2025-522896-27-00
4
2026-05-11
Asthma
-
2024-514754-79-00
4
2026-05-06
Pulmonary Arterial Hypertension (PAH)
-
2025-522279-27-00
5
2026-04-02
Newly Diagnosed AML with an NPM1 mutation
-
2025-521314-25-00
5
2026-03-19
NPM1-m and KMT2A-r Acute Myeloid Leukemia
-
2024-519579-24-00
5
2026-02-26
Classic Congenital Adrenal Hyperplasia
-
2024-520200-26-00
4
2026-02-13
Inherited anemias
-
2025-521558-40-00
5
2026-02-12
Pulmonary Hypertension Associated with Interstitial Lung Disease
-
2022-501607-27-00
7
2026-01-06
Relapsed or refractory B-cell Non-Hodgkin lymphoma
-
2024-518899-31-00
5
2025-12-19
Variant or wild-type transthyretin (TTR) amyloid cardiomyopathy
-
2025-521672-60-00
7
2025-12-19
Metastatic or locally advanced SST2-positive neuroendocrine neoplasms
-
2025-522070-36-00
5
2025-12-15
immune thrombocytopenia (ITP)
-
2025-521673-14-00
4
2025-12-03
Relapsed / Refractory Metastatic or Advanced Solid Tumors
-
2025-521268-37-00
6
2025-11-25
Respiratory tract diseases
-
2025-521511-40-00
10
2025-11-18
metastatic non-small cell lung cancer
-
2023-508057-19-00
5
2025-09-23
Advanced HER2-expressing Biliary Tract Cancer
-
2024-518589-29-00
5
2025-08-21
Bronchiectasis
-
2024-512753-24-00
5
2025-08-05
Acute Myeloid Leukemia (AML)
-
2024-518502-40-00
9
2025-07-28
Immune Thrombocytopenia
-
2024-516616-24-00
5
2025-07-23
Acromegaly
-
2024-517968-36-00
5
2025-07-08
non-small cell lung cancer